Takeda Pharmaceutical Company Limited 

(Public, TYO:4502)   Watch this stock   
Find more results for4502
Feb 3, 2010
Q3 2010 Earnings Conference Call and Webcast
Feb 3, 2010
Q3 2010 Earnings Conference Call and Webcast (Japanese)
Feb 3, 2010
Q3 2010 Earnings Release
  

Key stats and ratios

Q4 (Dec '09) 2009
Net profit margin 18.86% 15.42%
Operating margin 30.52% 19.92%
EBITD margin - 27.60%
Return on average assets 10.26% 8.46%
Return on average equity 13.57% 10.92%
Employees 19,769 -

Address

4-1-1 Doshomachi Chuo-ku
Osaka, OSK 540-8645
Japan
+81-6-62042111 (Phone)

Website links

Takeda Pharmaceutical Company Limited discussed on blogs

Takeda Pharmaceutical Company Limited discussions

Start a discussion about Takeda Pharmaceutical Company Limited »

Description

Takeda Pharmaceutical Company Limited is a Japan-based company engaged in the pharmaceutical business. The Company operates in three business segments. The Pharmaceutical segment is engaged in the manufacture and sale of pharmaceutical products, such as therapeutic substances for diabetes, circulatory drugs, digestive system drugs, hormonal agents, osteoporosis drugs, antibiotic agents, allergy medications and vitamin drops. The Health Care segment is engaged in the manufacture and sale of general drugs and medicines, as well as quasi drugs. The Others segment is involved in the manufacture and sale of reagents, clinical diagnostics and chemical products. The Company has 49 subsidiaries and 15 associated companies.

Officers and directors

Yasuchika Hasegawa
President, Representative Director
Age: 63
Makoto Yamaoka
Senior Managing Director, President of Subsidiary
Age: 63
Toyoji Yoshida
Managing Director
Age: 61
Shigenori Ohkawa
Executive Director
Age: 54
Alan MacKenzie
Executive Director
Age: 56
Yasuhiko Yamanaka
Chief Director of Pharmaceutical Sales, Director
Age: 53